Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, an ATP-competitive small molecule GSK-3 inhibitor, for treatment of difficult-to-treat cancers. Its lead programs include Elraglusib Injection for first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) and pediatric cancers, and an Elraglusib Oral Tablet in development. The company has treated over 500 patients in Phase 1 and 2 trials, with Phase 2 mPDAC data showing statistically significant improvement in median overall survival versus standard chemotherapy.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001683168-26-002257 | EDGAR | 79K words |
| 2025-03-13 | 2024-12-31 | 0001683168-25-001581 | EDGAR | 120K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001683168-26-006472 | EDGAR | 19K words |
| 2025-11-13 | 2025-09-30 | 0001683168-25-008323 | EDGAR | 24K words |
| 2025-08-14 | 2025-06-30 | 0001683168-25-006159 | EDGAR | 27K words |
| 2025-05-15 | 2025-03-31 | 0001683168-25-003705 | EDGAR | 24K words |
| 2024-11-13 | 2024-09-30 | 0001683168-24-007971 | EDGAR | 75K words |
| 2024-09-24 | 2024-06-30 | 0001683168-24-006623 | EDGAR | 74K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-17 | 0001683168-26-005616 | EDGAR | 1K words |
| 2026-01-12 | 0001683168-26-000217 | EDGAR | 1K words |
| 2025-11-28 | 0001683168-25-008732 | EDGAR | 27K words |
| 2025-11-21 | 0001683168-25-008618 | EDGAR | 1K words |
| 2025-09-10 | 0001683168-25-006831 | EDGAR | 1K words |
| 2025-06-26 | 0001683168-25-004766 | EDGAR | 18K words |
| 2025-06-05 | 0001683168-25-004258 | EDGAR | 15K words |
| 2025-06-02 | 0001683168-25-004117 | EDGAR | 4K words |
| 2025-05-23 | 0001683168-25-003995 | EDGAR | 1K words |
| 2025-05-06 | 0001683168-25-003163 | EDGAR | 1K words |
38 total filings indexed. 20 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001652935 |
| Ticker | ACTU |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.actuatetherapeutics.com |
| Listed | 2024-08-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ACTU (~200 tokens, structured JSON with cryptographic provenance)